The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1123-2017·Announced 2017-02-22

Physio-Control Recalls LIFEPAK 15 Defibrillators Due to Relay Failure

Physio-Control is recalling 338 LIFEPAK 15 defibrillators because an internal relay may fail, preventing the device from delivering defibrillation energy.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "The firm has become aware of a potential device issue where the LIFEPAK 15 device may no longer be able to deliver defibrillation energy due to a potential failure of an internal component (Relay) installed on the Therapy Printed Circuit…"

Plain-English summary

Physio-Control, Inc. is recalling 338 units of the LIFEPAK 15 Monitor, Automated External Defibrillator (AED). The recall involves 139 units in the United States and 199 units distributed internationally.

The firm identified a potential issue where the device may no longer be able to deliver defibrillation energy. This is caused by a potential failure of an internal component, specifically a Relay installed on the Therapy Printed Circuit Board Assembly (PCBA). The device is intended for use on adult and pediatric patients in manual mode, and for patients eight years of age and older in automated mode.

Affected units are distributed nationwide in the US and in numerous countries including Australia, Brazil, Canada, and the United Kingdom. Consumers and healthcare facilities should check their device serial numbers against the list provided in the official recall notice to determine if their unit is affected.

The recalled product

Product
LIFEPAK 15 Monitor, Automated External Defibrillator (AED), Manual mode monitoring and therapy functions are intended for use on adult and pediatric patients. Automated external defibrillation mode is intended for use on patients eight years of age and older.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • SERIAL NUMBERS: 42738872
  • 44554102
  • 42701550
  • 42702539
  • 42730815
  • 42800549
  • 42803986
  • 42862109
  • 42884428
  • 42944609
  • 42989327
  • 43022460
  • 43040692
  • 43048791
  • 43066974
  • 43116838
  • 43116994
  • 43119477
  • 43132954
  • 43133203

Distribution

Distributed nationwide across the United States.

The notice also names 33 states specifically:

Similar recalls